Sara Cajander Selected Research

HLA-DR alpha-Chains

10/2017	Expression of HLA-DRA and CD74 mRNA in whole blood during the course of complicated and uncomplicated Staphylococcus aureus bacteremia.
1/2016	Quantitative Real-Time Polymerase Chain Reaction Measurement of HLA-DRA Gene Expression in Whole Blood Is Highly Reproducible and Shows Changes That Reflect Dynamic Shifts in Monocyte Surface HLA-DR Expression during the Course of Sepsis.
10/2013	Preliminary results in quantitation of HLA-DRA by real-time PCR: a promising approach to identify immunosuppression in sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sara Cajander Research Topics

Disease

7	Sepsis (Septicemia) 01/2022 - 10/2013
5	COVID-19 01/2022 - 11/2020
5	Inflammation (Inflammations) 01/2022 - 01/2018
2	Infections 05/2021 - 10/2017
2	Bacteremia 01/2018 - 10/2017
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Heart Failure 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2020
1	Pneumonia (Pneumonitis) 08/2019
1	Lymphopenia (Lymphocytopenia) 01/2018
1	Cross Infection (Nosocomial Infection) 10/2013

Drug/Important Bio-Agent (IBA)

3	HLA-DR Antigens (HLA-DR)IBA 01/2018 - 10/2013
3	Messenger RNA (mRNA)IBA 10/2017 - 10/2013
3	HLA-DR alpha-ChainsIBA 10/2017 - 10/2013
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2019
2	C-Reactive ProteinIBA 03/2019 - 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	camostatIBA 05/2021
1	Serine Proteases (Serine Protease)IBA 05/2021
1	VaccinesIBA 04/2021
1	Pharmaceutical PreparationsIBA 04/2021
1	Hyaluronic Acid (Hyaluronan)IBA 11/2020
1	Secretory Leukocyte Peptidase InhibitorIBA 08/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2017
1	MHC class II transactivator proteinIBA 01/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2013

Therapy/Procedure

1	Critical Care (Surgical Intensive Care) 01/2021
1	Percutaneous Coronary Intervention 01/2021
1	Stents 01/2021